Tribune News Service
New Delhi, December 23
Indian basketball player Satnam Singh Bhamara’s year-long wait to know of his fate regarding his doping offence has finally ended after the Anti-Doping Disciplinary Panel (ADDP) sanctioned a two-year suspension period.
Bhamara, who is the first Indian to make it big in NBA after he was signed by Dallas Mavericks, was issued a provisional suspension in November last year after his sample showed presence of higenamine. Bhamara, 25, was tested on August 17 in Bangalore, where he was part of the Indian team preparing for the South Asian Games. The National Anti-Doping Agency (NADA) subsequently issued the provisional suspension on November 11.
Bhamara had argued that the substance found in his body came through a supplement he had bought. However, the ADDP panel stated that since Bhamara was a senior professional he should have exercised caution and was expected to know and follow the anti-doping rules.
The order means that Bhamara’s suspension will end on November 19 next year. “We got the order a couple of days back but we haven’t decided on lodging an appeal,” Bhamara’s lawyer Vidushpat Singhania said. “But we are still unhappy for the fact that it took them (NADA) over a year to finish up the hearing process when the stipulated time as per the WADA code is three months.”